Nasdaq
$1.41▲ 0.36%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $425.9MShares out 300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 8.20After-hours26.08.21 06:004Ownership#●●●#●●●
PROKIDNEY CORP.
Insider Brian JG Pereira of ProKidney Corp. filed a Form 4 on August 20, 2026, reporting a change in beneficial ownership of securities as of August 18, 2026. This filing is a standard disclosure of insider holdings and does not contain any material corporate events affecting the company's financial position or operations.…more
$1.41+0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.18After-hours26.08.19 05:42144Ownership
PROKIDNEY CORP.
ProKidney Corp. insider Brian JG Pereira filed an SEC Form 144 on August 18, 2026, to report a proposed sale of company shares. This filing serves as the formal notification of the insider's plan to dispose of their holdings.…more
$1.41+0.36%vs prev closeView filingShare - 8.18After-hours26.08.19 05:41144Ownership
PROKIDNEY CORP.
Insider Brian JG Pereira of ProKidney Corp. filed an SEC Form 144 on August 18, 2026, to report a plan for the sale of company shares. This is a standard procedure for an insider to dispose of their holdings.…more
$1.41+0.36%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:45#●●●#●●●
ProKidney to Host Virtual KOL Event on Rilparencel
ProKidney will host a virtual event with key opinion leaders to discuss the mechanism of action and research findings for its kidney disease therapy, rilparencel. The company will also provide a corporate update during the session.…more
$1.41+0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 3d agoPre-market26.10.22 21:00
●●●●●●●● ●●●●● ●●●●●●
ProKidney will present eight research abstracts regarding its kidney disease therapy candidate at the upcoming American Society of Nephrology’s Kidney Week. This event focuses on sharing academic data and does not represent immediate regulatory approval or financial impact.…more
$1.41+0.36%vs prev close - 10.2Pre-market26.10.02 22:00
●●●●●●●● ●●●●● ●●●●●●
ProKidney will present eight abstracts at the American Society of Nephrology’s Kidney Week, highlighting new clinical and mechanistic data for its CKD therapy, rilparencel. The presentations aim to reinforce the safety profile and therapeutic potential observed in earlier Phase 2 studies.…more
$1.41+0.36%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report